- Home
- HPH vs TSVT Comparison
HPH vs TSVT Comparison
Compare HPH & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPH
- TSVT
- Stock Information
- Founded
- HPH 2010
- TSVT 2021
- Country
- HPH China
- TSVT United States
- Employees
- HPH N/A
- TSVT N/A
- Industry
- HPH
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- HPH
- TSVT Health Care
- Exchange
- HPH NYSE
- TSVT Nasdaq
- Market Cap
- HPH 137.1M
- TSVT 128.5M
- IPO Year
- HPH 2019
- TSVT N/A
- Fundamental
- Price
- HPH $0.27
- TSVT $2.61
- Analyst Decision
- HPH
- TSVT Buy
- Analyst Count
- HPH 0
- TSVT 6
- Target Price
- HPH N/A
- TSVT $10.40
- AVG Volume (30 Days)
- HPH 142.5K
- TSVT 449.7K
- Earning Date
- HPH 01-01-0001
- TSVT 03-04-2025
- Dividend Yield
- HPH N/A
- TSVT N/A
- EPS Growth
- HPH N/A
- TSVT N/A
- EPS
- HPH N/A
- TSVT N/A
- Revenue
- HPH $286,996,105.00
- TSVT $45,620,000.00
- Revenue This Year
- HPH N/A
- TSVT N/A
- Revenue Next Year
- HPH N/A
- TSVT $36.09
- P/E Ratio
- HPH N/A
- TSVT N/A
- Revenue Growth
- HPH 1722.42
- TSVT N/A
- 52 Week Low
- HPH $0.23
- TSVT $2.35
- 52 Week High
- HPH $10.06
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- HPH 39.75
- TSVT 38.77
- Support Level
- HPH $0.23
- TSVT $2.36
- Resistance Level
- HPH $0.29
- TSVT $2.53
- Average True Range (ATR)
- HPH 0.05
- TSVT 0.18
- MACD
- HPH -0.00
- TSVT 0.00
- Stochastic Oscillator
- HPH 15.83
- TSVT 30.29
About HPH HIGHEST PERFORMANCE HLDGS INC
Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. It focuses on providing personalized wealth management services for emerging middle-class and affluent families, comprehensive support services for financial planners, and diversified financial services for institutional clients.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.